Welcome to our dedicated page for Cronos Group news (Ticker: CRON), a resource for investors and traders seeking the latest updates and insights on Cronos Group stock.
Cronos Group Inc. reports developments for a global cannabis and cannabinoid company focused on consumer goods, cannabis research, technology and product development. Its brand portfolio includes Spinach®, PEACE NATURALS®, LIT® and Lord Jones®, with news often centered on product innovation across Canadian cannabis formats such as pre-rolls and vapes.
Recurring Cronos updates also cover operating and financial results, earnings conference calls, annual shareholder meetings, proxy and governance matters, capital-structure disclosures and public-company presentations. The company’s disclosures connect brand launches and R&D-driven product development with the financial and governance reporting of a Nasdaq- and TSX-listed cannabis issuer.
Cronos Group has entered into a strategic agreement to purchase an option for a 10.5% stake in PharmaCann for approximately $110.4 million. This investment positions Cronos to benefit from the expanding U.S. cannabis market, particularly in states where PharmaCann operates, which includes six limited-license states. Both companies plan to collaborate on product distribution and governance rights following the option's exercise, contingent on regulatory approvals and U.S. federal cannabis legalization.
Cronos Group (NASDAQ: CRON) and Ginkgo Bioworks have amended their collaboration agreement to expedite the commercialization of cultured cannabinoids. The new terms allow Cronos to market products using cultured cannabinoids before meeting previously defined productivity targets, enhancing their market position in Canada. Following the receipt of necessary licenses, Cronos has commenced commercial production of CBG. The agreement maintains the original share issuance structure tied to productivity milestones, with the potential to produce rare cannabinoids reliably and economically.
Cronos Group, a global cannabinoid company, announced that Mike Gorenstein, Executive Chairman, will speak at Canaccord Genuity’s 5th Annual Global Cannabis Conference on May 11, 2021, at 2:30 p.m. EDT. Participants can access the live webcast at thecronosgroup.com. Following the event, a replay will be available. Cronos is focused on developing disruptive intellectual property and building a strong brand portfolio with products like PEACE NATURALS, COVE, and Spinach.
Cronos Group (NASDAQ: CRON) has unveiled a comprehensive Marketing Code aimed at promoting responsible marketing practices in the cannabis industry. This initiative emphasizes that marketing should not target individuals below the legal consumption age. The code will govern all Cronos marketing activities worldwide and is intended to engage both industry peers and policymakers. Key principles include adult-targeted advertising, responsible consumption messaging, and transparency in claims. Cronos Group's leadership believes this initiative is vital for fostering trust in the evolving cannabis market.
Cronos Group recently announced its Q1 2021 results, reporting consolidated net revenue of $12.6 million, a 50% increase from Q1 2020, driven by growth in the Canadian and Israeli markets. Despite increased sales, the company experienced a gross loss of $2.96 million, improved from $6.48 million a year prior. The newly acquired processing license for cannabinoid biosynthesis is a significant achievement, supporting innovative product development. However, adjusted EBITDA loss slightly increased to $37.1 million, reflecting higher marketing and R&D costs.
Cronos Group Inc. (NASDAQ: CRON) will hold its 2021 Annual Meeting of Shareholders on June 25, 2021, at 11:00 a.m. EDT in a virtual format due to COVID-19 health concerns. Shareholders and proxyholders can participate online, ask questions, and vote. The proxy statement with meeting details is available on the Company’s website. A replay of the meeting will be accessible within 24 hours post-event. Cronos Group, a global cannabinoid company, focuses on advancing cannabis research and product development, aiming to enhance consumer experience through a diverse brand portfolio.
Cronos Group Inc. (NASDAQ: CRON) will host its 2021 First Quarter Earnings Conference Call on May 7, 2021, at 8:30 a.m. EDT. The call will allow management to discuss the company's financial results and address questions from investors. A live audio webcast will be available on the company's website, with an archived replay afterward. Cronos Group focuses on cannabinoid production and is building a diverse brand portfolio, including various wellness and hemp-derived CBD brands.
Cronos Group announces the launch of its first brand campaign for the Lord Jones™ brand, named “A Higher Order”, aimed at expanding its market presence in the U.S. This campaign includes out-of-home advertising and television spots featuring new creative assets, which showcase the brand's premium CBD products. The initiative reflects the brand's evolution and commitment to elevating consumer wellness experiences.
The campaign will be celebrated with a live-streamed “Sunday Bath Session” on May 2, 2021.
Cronos Group (NASDAQ: CRON) has announced that its Happy Dance CBD skincare line is now available at over 550 Ulta Beauty locations and online. This marks the brand's first entry into physical retail, enhancing its visibility and accessibility. Happy Dance, co-founded by actress Kristen Bell, features vegan, cruelty-free products, with a portion of profits supporting a Black-owned reentry project. The partnership is highlighted by a dedicated display in Ulta stores, aiming to appeal to a wider audience and promote self-care.
Cronos Group announced its 2020 fourth quarter and full-year results, revealing a net revenue increase of 133% in Q4 2020 compared to Q4 2019, reaching $17.0 million. The company also saw significant growth in the U.S. and Israeli markets. However, a gross loss of $14.9 million was reported, despite a $5.2 million improvement from the previous year. The company holds approximately $1.3 billion in cash and short-term investments. Significant investments in brand expansion include the launch of Happy Dance™ products at ULTA Beauty™, enhancing its portfolio in the U.S. market.